Views

CrossRef citations to date

Altmetric

Original Articles: Clinical

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience

Vijaya R. BhattDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA, Correspondence[email protected]

Fausto R. Loberiza JrDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

Lynette M. SmithDepartment of Biostatistics College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA, and

James O. ArmitageDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

Timothy C. GreinerDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

Martin BastDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

Matthew A. LunningDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

Philip J. BiermanDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

Julie M. VoseDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

R. Gregory BociekDepartment of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA,

show all

Supplemental material

Supplementary Table 2. Multivariate analysis for risk of death utilizing two subtypes of mantle cell lymphoma.

Download MS Word (39 KB)

Supplementary Table 1. Use of hematopoietic stem cell transplant based on induction therapy.

Download MS Word (32.5 KB)

Supplementary Figure 2. Overall survival of subtypes of mantle cell lymphoma treated between 2000-2012.

Download JPEG Image (79.6 KB)

Supplementary Figure 1. Overall survival of subtypes of mantle cell lymphoma treated between 1984-2000.

Download JPEG Image (83.2 KB)

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (10.5 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience

Supplementary Table 2. Multivariate analysis for risk of death utilizing two subtypes of mantle cell lymphoma.

Supplementary Table 1. Use of hematopoietic stem cell transplant based on induction therapy.

Supplementary Figure 2. Overall survival of subtypes of mantle cell lymphoma treated between 2000-2012.

Supplementary Figure 1. Overall survival of subtypes of mantle cell lymphoma treated between 1984-2000.

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience

Supplementary Table 2. Multivariate analysis for risk of death utilizing two subtypes of mantle cell lymphoma.

Supplementary Table 1. Use of hematopoietic stem cell transplant based on induction therapy.

Supplementary Figure 2. Overall survival of subtypes of mantle cell lymphoma treated between 2000-2012.

Supplementary Figure 1. Overall survival of subtypes of mantle cell lymphoma treated between 1984-2000.

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date